Company / EPS (Basic)
ROCKET PHARMACEUTICALS, INC. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.73
FY2025
5-year range
-$3.26 / -$1.58
FY2021-FY2025
Trend
+16.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) returned to growth in FY2025 after 3 years of decline, reaching $-2.73.
Based on SEC 10-K filings.
-2.73 in FY2025.
Declined from $-2.67 to $-2.73 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 16.3% year-over-year.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.73 | +16.3% |
| FY2024 | -$3.26 | -22.1% |
| FY2023 | -$2.67 | -6.0% |
| FY2022 | -$2.52 | -59.5% |
| FY2021 | -$1.58 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026